In the presence of the Italian Ambassador to Doha, Mr. Pasquale Salzano, Sheikh Faisal Bin Qassim Al Thani – Chairman of Aamal Company Q.P.S.C., and Mr. Fabio Rossi – GPI’s International Sales Director, signed the agreement for the Warehouse Automation.
On this occasion, Sheikh Faisal Bin Qassim Al Thani, Chairman of Aamal Company Q.P.S.C., commented: “The Warehouse Automation will be an important enhancement of our operations, as we continue to keep up with the latest technological advancements, and support our subsidiaries to optimize their performance. At Aamal, we are keen to bring the latest products and solutions to the market, in order to be a pioneer in the market and partner with blue-chip companies such as GPI.”
In turn, Mr. Sherif Shehata, General Manager of Ebn Sina Medical, commented: “It’s my pleasure to sign our second cooperation agreement with the GPI Group, our Italian healthcare partner. The Warehouse Automation should have a significant positive impact on our operations, and we are always on the lookout for such agreements that bring improvement to our processes. People can come and see how this Robot works and its benefits, which we hope will be a model that all other healthcare providers would follow.”
Mr. Fabio Rossi, GPI’s International Sales Director, commented: “It is our pleasure to expand our operations in the Qatari market through the leading Ebn Sina Medical Company, and we are also glad to contribute to enhancing the automation of the Medical sector in Qatar. We look forward to further collaboration in the future.”
This announcement is not considered price-sensitive information. Referencing Articles (47), (50), and (58) of QFMA’s Rulebook on Offering and Listing of Securities and QFMA’s instructions on the disclosure of significant non-financial information that has impact on the share price of a listed company, this corporate development doesn’t fall under the scope of the rules and regulations concerning disclosing non-financial price-sensitive information.
For further enquiries, please contact:
Laura Ackel – Marketing and Communictions Officer
(+97466716576 / firstname.lastname@example.org )
Aamal is one of the region’s fastest growing diversified conglomerates and has been listed on the Qatar Stock Exchange since December 2007. As at 25 June 2019, the Company had a market capitalisation of QAR 5.0 bn (US$ 1.4 bn).
Aamal’s operations are widely diversified and comprise 26 active business units (subsidiaries and joint ventures) with market leading positions in the key industrial, retail, property, managed services, and medical equipment and pharmaceutical sectors, thereby offering investors a high quality and balanced exposure to Qatar’s wider economic growth and development. Aamal is focused on self-financed and profitable growth, delivering an average increase in underlying profits in excess of 11.1% (i.e. before fair value gains on investment properties) over the twelve years to end-2018.
For further information on Aamal Company, please refer to the corporate website: aamal.com.qa
Ebn Sina Medical Company:
Ebn Sina Medical is the leading pharmaceutical distribution company in Qatar with exclusive distribution agreements with more than 60 multinational pharmaceutical companies. It is active in the importation, distribution, promotion and retailing of pharmaceuticals, appliances and disposables in addition to consumer products.
Ebn Sina Medical provides complete professional services to Government, Semi- government, and the private local market including retail pharmacies, private hospitals, polyclinics, private clinics, industrial companies etc.
Alongside this professional knowledge and expertise, Ebn Sina Medical conforms to all Qatar regulatory requirements and has implemented frequently updated quality management systems. Ebn Sina Medical is a registered trademark in Qatar.
GPI Group, listed on the Borsa Italiana on the MTA market, is the preferred partner in Italy for technology and services dedicated to Health and Social Care and the Public Administration. Founded 30 years ago, over time GPI has constantly grown in both size and expertise. It currently has more than 4,000 employees and operates with several branches throughout Italy and abroad.
Thanks to the specialised expertise passed on from the companies who became part of the GPI ecosystem and the significant investments in product and process innovation applied to the e-health, e-welfare and e-government sectors, the Group has successfully translated the drivers emerging from the world of Health Care into cutting-edge technological solutions and new service models. Expertise in IT, design, and consultancy skills allow it to operate in different business areas: Software, Care, Automation, ICT and Pay.
© Press Release 2019